PRESENTATION

Q4 2021 — Earnings presentation

Q4 2021PDF · 15 pages356 KB
2021
Fourth Quarter
Earnings
(Unaudited)
January 25, 2022

-- 1 of 15 --

22	2021 Q4 Earnings – January 25, 2022. All rights reserved.
Events
Upcoming events
Strategic Update and
2022 Outlook meeting February 14
Q1 earnings April 26

-- 2 of 15 --

33	2021 Q4 Earnings – January 25, 2022. All rights reserved.
Forward looking statement
This presentation contains forward-looking information about 3M's financial results and estimates and business prospects that involve substantial risks and
uncertainties. You can identify these statements by the use of words such as "anticipate," "estimate," "expect," "aim," "project," "intend," "plan," "believe," "will,"
"should," "could," "target," "forecast" and other words and terms of similar meaning in connection with any discussion of future operating or financial performance
or business plans or prospects. Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, regulatory,
capital markets and other external conditions and other factors beyond the Company's control, including natural and other disasters or climate change affecting the
operations of the Company or its customers and suppliers; (2) risks related to public health crises such as the global pandemic associated with the coronavirus
(COVID-19); (3) foreign currency exchange rates and fluctuations in those rates; (4) liabilities related to certain fluorochemicals, including lawsuits concerning
various PFAS-related products and chemistries, and claims and governmental regulatory proceedings and inquiries related to PFAS in a variety of jurisdictions; (5)
legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual Report on Form
10-K for the year ended Dec. 31, 2020, and any subsequent quarterly reports on Form 10-Q (the “Reports”); (6) competitive conditions and customer preferences;
(7) the timing and market acceptance of new product offerings; (8) the availability and cost of purchased components, compounds, raw materials, labor, and energy
(including oil and natural gas and their derivatives) due to shortages, increased demand and wages, logistics, manufacturing site disruption or supply chain
interruptions (including those caused by natural and other disasters and other events); (9) unanticipated problems or delays with the phased implementation of a
global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) the
impact of acquisitions, strategic alliances, divestitures and other unusual events resulting from portfolio management actions and other evolving business
strategies, and possible organizational restructuring; (11) operational execution, including scenarios where the Company generates fewer productivity
improvements than estimated; (12) financial market risks that may affect the Company’s funding obligations under defined benefit pension and postretirement
plans; (13) the Company's credit ratings and its cost of capital; and (14) tax-related external conditions, including changes in tax rates, laws or regulations. Changes
in such assumptions or factors could produce significantly different results. A further description of these factors is located in the Reports under "Cautionary Note
Concerning Factors That May Affect Future Results" and "Risk Factors" in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly
Reports), as updated by applicable Current Reports on Form 8-K. The information contained in this presentation is as of the date indicated. The Company assumes
no obligation to update any forward-looking statements contained in this presentation as a result of new information or future events or developments.
This presentation refers to certain non-GAAP financial measures. Refer to 3M’s January 25, 2022, press release for descriptions of non-GAAP financial measures
such as free cash flow, adjusted free cash flow, free cash flow conversion, adjusted free cash flow conversion, net debt, adjusted EBITDA, and various measures
that adjust for the impacts of special items. These non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures. Reconciliations of
these non-GAAP financial measures to the most directly comparable GAAP financial measures can be found in that press release.
Note on non-GAAP financial measures

-- 3 of 15 --

44	2021 Q4 Earnings – January 25, 2022. All rights reserved.
KEY TAKEAWAYS
• Delivered solid Q4 results in the face of continued fluid environment
• December better than expected:
o Effectively managed significant disruptions in global supply chains and logistics challenges to serve customers;
o Strong focus on productivity actions and spending discipline; and
o COVID-19 Omicron variant driving an increase in near-term demand for disposable respirators
• Selling price momentum gaining traction as previously communicated
• Overall end-market demand remains strong and longer term we are well-positioned for driving growth in large, attractive
markets including automotive, home improvement, safety, healthcare, and electronics
• Portfolio prioritization: announced divestitures of food safety and floor care products business to enhance shareholder value
• Capital allocation priorities: growth, productivity and sustainability, while returning significant capital to shareholders
• Full-year 2022 guidance to be provided on February 14 at Strategic Update and 2022 Outlook meeting
Organic local-
currency growth
Operating
margin
Earnings
per share
+1.3% 18.8% $2.31	Q4 2021
Serving customers while navigating external challenges

-- 4 of 15 --

55	2021 Q4 Earnings – January 25, 2022. All rights reserved.
Q4 2021 operating margin and EPS
+9.0%
Operating
margin
Earnings
per share
Q4 2020 21.5% $2.41
Organic volume/
productivity
and other
-2.4% -$0.33
• Org vol impact -1.3%
• Manufacturing headwinds from global supply chain challenges and increased comp/benefits
costs more than offsetting strong spending discipline and benefits from restructuring actions
• Increased investments in growth, productivity and sustainability
• Lower restructuring charges (margin/EPS YoY impact: +140 bps/+$0.18)
• Lower gain on sales of properties (margin/EPS YoY impact: -60 bps/-$0.08)
• Smaller increase in respirator mask reserve; higher litigation-related costs
Price/raw material -0.2% +$0.03 • Selling price actions mitigating raw material and logistics cost inflation
FX -0.1% -$0.04 • Net of hedge impact
Other expense/income NA +$0.10 • Primarily non-operating pension benefit and lower net interest expense
Tax rate* NA +$0.12 • Q4 2021 tax rate 14.5% versus 18.6% in prior year
Shares outstanding NA +$0.02 • Average diluted shares down 1%
Q4 2021 18.8% $2.31
* The effect of income taxes on items that had specific tax rates are reflected within their respective impacts in the table above.

-- 5 of 15 --

66	2021 Q4 Earnings – January 25, 2022. All rights reserved.
Q4 2021 cash flow and balance sheet
Proactive balance sheet management
• Net debt of $12.6B, down $1.2B, or 8% YoY
Adjusted free cash flow
• Q4: $1.5B, down 30%; FY: $6.0B, down 11%
Adjusted free cash flow conversion
• Q4: 110%, down 40 ppts; FY: 101%, down 30 ppts
• Q4 YoY decline due to lower non-cash expenses vs. Q4 2020 (legal and
restructuring), higher litigation-related payments and capex investments,
partially offset by improvements in the working capital cycle
Capital expenditures
• Q4: $556M, up $134M; FY: $1.6B, up $102M
Cash returned to shareholders
• Q4: dividends $848M; gross share repurchases $938M
• FY: dividends $3.4B; gross share repurchases $2.2B
$1.5B
-30% year-on-year
Adjusted free cash
flow
110%
-40 ppts year-on-year
Adjusted free cash
flow conversion
$1.8B
+110% year-on-year
Cash returned to
shareholders

-- 6 of 15 --

77	2021 Q4 Earnings – January 25, 2022. All rights reserved.
Business Group performance
FY 2021 Q4 2021
Organic
growth
Operating
margin
Organic
growth
Operating
margin Q4 commentary
Safety &
Industrial
7.8%
20.9%
-1.3%
17.7%
• Organic growth led by strength in closure and masking systems, abrasives, industrial adhesives and tapes and electrical
markets, more than offset by personal safety declines due to prior-year strong COVID-related respiratory demand
(disposable respirator decline reduced segment organic growth by ~4 ppts)
• Disposable respirator sales declined 25% organically YoY, and 7% sequentially
• Operating margins -4.4 ppts YoY; increased raw materials, logistics and litigation-related costs; manufacturing productivity
impacts; and lower gain on sales of properties, partially offset by selling price actions; strong spending discipline; smaller
increase in respirator mask reserve; restructuring benefits and lower YoY related charges
Transportation
& Electronics
9.0%
20.6%
-0.4%
17.6%
• Organic growth led by commercial solutions and advanced materials; organic sales declined in electronics and auto OEM
(due to continued impact of semiconductor constraints) and transportation safety
• Operating margins -2.7 ppts YoY; increased raw materials and logistics costs; manufacturing productivity impacts; and
increased comp/benefits costs, partially offset by selling price actions; strong spending discipline; restructuring benefits and
lower YoY related charges
Health Care
8.6%
23.8%
1.6%
23.6%
• Organic growth led by separation and purification sciences, food safety, health information systems and oral care, partially
offset by medical solutions declines due to lower YoY disposable respirator sales (disposable respirator decline reduced
segment organic growth by ~4 ppts)
• Operating margins -0.5 ppts YoY; increased raw materials and logistics costs; food safety deal-related costs; manufacturing
productivity impacts; and increased comp/benefits costs, partially offset by sales growth (including selling price actions);
strong spending discipline; restructuring benefits and lower YoY related charges
Consumer
9.3%
21.3%
4.9%
21.4%
• Organic growth led by office and stationery, consumer health and safety, and home improvement
• Operating margins -1.0 ppt YoY; increased raw materials, logistics and outsourced hardgoods manufacturing costs;
manufacturing productivity impacts; and increased comp/benefits costs, partially offset by sales growth (including selling
price actions); strong spending discipline; restructuring benefits and lower YoY related charges

-- 7 of 15 --

88	2021 Q4 Earnings – January 25, 2022. All rights reserved.
2021 full-year performance and highlights
Organic local-currency growth
8.8%
Earnings per share
$10.12
Adj. free cash flow conversion
101%
• Generated broad-based organic growth across businesses and invested in large and attractive end-markets that align with
key global trends
• Executed well with good margins, strong earnings per share and free cash flow despite significant raw materials and
logistics cost inflation and global supply chain challenges
• Accelerating ESG leadership: investing $1 billion over the next 20 years to accelerate air and water stewardship; new
plastics reduction goals; and introduced diversity, equity and inclusion report
• Prioritizing portfolio management, including announced divestitures of food safety and floor care products business to
enhance shareholder value
• Focused on transformation including accelerating our digital strategy to better serve customers and improve efficiency of
operations and successfully executed our restructuring program that was announced in December 2020
• Generated $6 billion of adjusted free cash flow and strengthened the balance sheet providing financial flexibility while
returning $5.6 billion to shareholders

-- 8 of 15 --

99	2021 Q4 Earnings – January 25, 2022. All rights reserved.
Q&A
Mike Roman
Chairman of the Board &
Chief Executive Officer
Monish Patolawala
Executive Vice President, Chief
Financial & Transformation Officer
Bruce Jermeland
Senior Vice President,
Investor Relations

-- 9 of 15 --

10	10	2021 Q4 Earnings – January 25, 2022. All rights reserved.
Appendix

-- 10 of 15 --

11	11	2021 Q4 Earnings – January 25, 2022. All rights reserved.
Q4 2021 P&L
($M)
Q4
2020
Q4
2021 Change
Sales $8,583 $8,612 +0.3%
Gross profit $4,195 $3,914 -6.7%
% to sales 48.8% 45.5% -3.3 pts
SG&A $1,890 $1,824 -3.4%
% to sales 22.0% 21.2% -0.8 pts
R&D & related $456 $474 +4.0%
% to sales 5.3% 5.5% +0.2 pts
Gain on sale of businesses — — —
% to sales — — —
Operating income $1,849 $1,616 -12.6%
% to sales 21.5% 18.8% -2.7 pts
Net income $1,405 $1,339 -4.7%
GAAP earnings per share $2.41 $2.31 -4.1%

-- 11 of 15 --

12	12	2021 Q4 Earnings – January 25, 2022. All rights reserved.
Q4 2021 sales recap
Americas EMEA APAC Worldwide
Organic volume -1.7% -3.2% +0.2% -1.3%
Price +3.9% +1.3% +1.2% +2.6%
Organic local-currency +2.2% -1.9% +1.4% +1.3%
Acquisitions/divestitures —% —% —% —%
FX -0.1% -2.6% -1.6% -1.0%
Total growth +2.1% -4.5% -0.2% +0.3%
U.S. Canada Mexico Brazil China/HK Japan
Organic local-currency +1% +6% +9% +4% +2% -6%

-- 12 of 15 --

13	13	2021 Q4 Earnings – January 25, 2022. All rights reserved.
Business segment information
($M) Net Sales Q4 2021 Sales Growth
Organic local-currency
by Geographic Area
Business Segment Operating
Income/Adjusted Operating
Income*
Business Segment
Operating
Margin/Adjusted
Operating Margin*
Business groups
Q4
2020
Q4
2021
Organic
local-
currency FX M&A
Total
Sales
Change Americas
Asia
Pacific EMEA
Q4
2020
Q4
2021
Percent
change
Q4
2020
Q4
2021
Safety & Industrial $3,133 $3,064 -1.3% -0.9% —% -2.2% -3.3% 8.7% -7.4% $693 $543 -21.7% 22.1% 17.7%
Transportation &
Electronics $2,341 $2,306 -0.4% -1.1% —% -1.5% 6.7% -4.5% 2.0% $476 $406 -14.7% 20.3% 17.6%
Health Care $2,258 $2,275 1.6% -0.9% —% 0.7% 0.1% 9.7% -0.9% $544 $536 -1.6% 24.1% 23.6%
Consumer $1,418 $1,476 4.9% -0.8% —% 4.1% 6.0% 4.4% -2.1% $317 $316 -0.4% 22.4% 21.4%
Elimination of Dual
Credit $(566) $(509) $(147) $(125)
Total Operating
Business Segment $1,883 $1,676
Corporate & Unallocated $(1) $— $(34) $(60)
Total $8,583 $8,612 1.3% -1.0% —% 0.3% 2.2% 1.4% -1.9% $1,849 $1,616 -12.6% 21.5% 18.8%
* “Corporate and Unallocated” and “Total” provided on an adjusted basis
Organic local-currency = organic volume + price

-- 13 of 15 --

14	14	2021 Q4 Earnings – January 25, 2022. All rights reserved.
Additional sales detail
($M) Net Sales
Business groups Q4 2020 Q4 2021
Abrasives 318 343
Automotive Aftermarket 305 302
Closure and Masking Systems 248 272
Electrical Materials 292 306
Industrial Adhesives & Tapes 683 718
Personal Safety 1,212 1,024
Roofing Granules 95 90
Other Safety & Industrial (20) 9
Total Safety & Industrial Business Group 3,133 3,064
Advanced Materials 266 280
Automotive & Aerospace 488 433
Commercial Solutions 381 417
Electronics 999 974
Transportation Safety 212 191
Other Transportation & Electronics (5) 11
Total Transportation & Electronics Business Group 2,341 2,306
($M) Net Sales
Business groups Q4 2020 Q4 2021
Drug Delivery — —
Food Safety 89 94
Health Information Systems 307 323
Medical Solutions 1,316 1,285
Oral Care 335 341
Separation & Purification Sciences 214 227
Other Health Care (3) 5
Total Health Care Business Group 2,258 2,275
Consumer Health & Safety 132 148
Home Care 270 268
Home Improvement 625 638
Stationery & Office 354 387
Other Consumer 37 35
Total Consumer Business Group 1,418 1,476
Corporate & Unallocated (1) —
Elimination of Dual Credit (566) (509)
Total 8,583 8,612

-- 14 of 15 --



-- 15 of 15 --